Risk in drug trials
- 1 December 2006
- journal article
- Published by Elsevier in The Lancet
- Vol. 368 (9554) , 2205
- https://doi.org/10.1016/s0140-6736(06)69881-4
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Establishing risk of human experimentation with drugs: lessons from TGN1412The Lancet, 2006
- T-Cell Costimulation — Biology, Therapeutic Potential, and ChallengesNew England Journal of Medicine, 2006
- Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412New England Journal of Medicine, 2006
- Volunteers at RiskNew England Journal of Medicine, 2006
- “Special Scrutiny”: A Targeted Form of Research Protocol ReviewAnnals of Internal Medicine, 2004